Gamma Probe and Ultrasound Guided Fine Needle Aspiration Cytology of the Sentinel Node Trial
Suspended
- Conditions
- Melanoma, Breast Cancer, Sentinel Lymph Node Biopsy, FNA/FNAC, SurgeryMelanoom, Mammacarcinoom, Schildwachtklierbiopsy, FNA, Chirurgie
- Registration Number
- NL-OMON21922
- Lead Sponsor
- Erasmus MC Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
New diagnosis of cT1b-4N0M0 cutaneous melanoma or cT1-3N0M0 breast cancer
- Age ≥ 18 years
Exclusion Criteria
- Clinically suspect lymph node
- Other known malignancy with potential to disseminate to axillary or groin lymph node basins.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity of combined gamma probe and ultrasound guided FNAC of the SN<br>
- Secondary Outcome Measures
Name Time Method 1) SN identification rate >75%<br /><br>2) Histological results of core needle biopsy versus sentinel node biopsy (surgery) and versus FNAC.